Optimizing care for psoriatic patients requiring systemic therapies: how will COVID-19 disease transform risk perceptions?

Autor Talamonti, M., Tofani, L., Bianchi, L., Galluzzo, M.
Vydáno v Arch Dermatol Res (2020)

Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date

Autor Galluzzo, M, D’Adamio, S, Massaro, A, Piccolo, A, Bianchi, L, Talamonti, M
Vydáno v Clin Cosmet Investig Dermatol (2019)

Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab

Autor Signa, S., Campione, E., Rusmini, M., Chiesa, S., Grossi, A., Omenetti, A., Caorsi, R., Viglizzo, G. M., Galluzzo, M., Bianchi, L., Talamonti, M., Orlandi, A., Martini, A., Ceccherini, I., Gattorno, M.
Vydáno v Pediatr Rheumatol Online J (2019)

Response to IL‐17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein‐coding and untranslated regions of the IL‐17A gene: results from a...

Autor van Vugt, L.J., van den Reek, J.M.P.A., Meulewaeter, E., Hakobjan, M., Heddes, N., Traks, T., Kingo, K., Galluzzo, M., Talamonti, M., Lambert, J., Coenen, M.J.H., de Jong, E.M.G.J.
Vydáno v J Eur Acad Dermatol Venereol (2019)

Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy

Autor Talamonti, M., Galluzzo, M., Chiricozzi, A., Quaglino, P., Fabbrocini, G., Gisondi, P., Marzano, A.V., Potenza, C., Conti, A., Parodi, A., Belloni Fortina, A., Bardazzi, F., Argenziano, G., Rongioletti, F., Stingeni, L., Micali, G., Loconsole, F., Venturini, M., Bongiorno, M.R., Feliciani, C., Rubegni, P., Amerio, P., Fargnoli, M.C., Pigatto, P., Savoia, P., Nisticò, S.P., Giustini, S., Carugno, A., Cannavò, S.P., Rech, G., Prignano, F., Offidani, A., Lombardo, M., Zalaudek, I., Bianchi, L., Peris, K.
Vydáno v J Eur Acad Dermatol Venereol (2020)